BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Chimerix, Inc. 

2505 Meridian Parkway
Ste 340
Durham  North Carolina  27713  U.S.A.
Phone: 919-806-1074 Fax: 919-806-1146


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Chimerix (CMRX) Provides Update On Anticipated SUPPRESS Enrollment 2/26/2015 7:56:54 AM
Chimerix (CMRX) To Present At The Cowen and Company 35th Annual Health Care Conference 2/25/2015 10:49:47 AM
TRICON: Chimerix (CMRX): Antivirals Are Undergoing a Renaissance, As Infectious Disease Comes Front and Center 2/18/2015 12:01:26 PM
EXCLUSIVE: Chimerix (CMRX) Says 2015 Will Be "Pivotal" Year, In Talks With Regulators to Use Antiviral After Transplants 2/18/2015 11:39:56 AM
Chimerix, Inc. (CMRX) Presents Update On Preliminary Data From Advise Study Of Brincidofovir For Adenovirus Infection At BMT Tandem Meetings 2/12/2015 7:54:25 AM
Chimerix, Inc. (CMRX) Focusing Efforts On CMV And Adenovirus Pivotal Trials 2/2/2015 7:38:56 AM
Chimerix, Inc. (CMRX) Abandons Testing of Experimental Ebola Drug in Liberia 2/2/2015 5:56:51 AM
Chimerix, Inc. (CMRX) Receives Notice Of Allowance For Brincidofovir Composition Of Matter Patent Extending Exclusivity To 2034 1/12/2015 6:54:14 AM
Chimerix, Inc. (CMRX) Provides Update On Brincidofovir Pivotal Phase 3 Advise Trial For The Treatment Of Adenovirus 1/8/2015 7:47:27 AM
Chimerix, Inc. (CMRX) To Present At The 33rd Annual J.P. Morgan Healthcare Conference 1/7/2015 10:13:26 AM
12345678910...